Multi-Omics Reveal Antioxidant Effects of Bardoxolone Methyl in the Phase 2 Study of Bardoxolone Methyl in Patients with CKD and Type 2 Diabetes Study.

ABSTRACT:

SUBMITTER: Yoshioka K 

PROVIDER: S-EPMC12626677 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature